Search

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

How is the business of making medicine changing in light of the COVID-19 pandemic?

There are ample opportunities for pharma companies to transition to greener chemical processes. Martin Hayes from Johnson Matthey tells us more.

We need to optimize and then accelerate HPAPI drug product development. Alyn McNaughton from Lonza tells us more.

Solving a decades-old mystery, researchers have discovered how non-ribosomal peptide synthetases work.

Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.

Sitting Down With... JoyL Silva, General Manager at PfizerCentre.

GenScript has manufacturing sites across China and branch offices across the world. We find out more about their new segment, GenScript ProBio.

How can drugs be modified to lessen their adverse effects?

Third place in The Medicine Maker 2019 Innovation Awards went to Colorcon’s StarTab – a starch-based excipient for direct compression.